Dupixent 300 MG/2 ML pen 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26FF111
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $16,628
Award facts
- Contract value 100% obligated
- $16,628.06 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $16,628.06 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Dupixent 300 mg/2 mL pens (2 mL units) on February 3, 2026, with an ultimate completion date of February 4, 2026. This non-competitive delivery order represents a single task order placed against AmerisourceBergen's parent company, Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical valued at up to $999.99 million through December 31, 2031. The product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Dupixent (dupilumab) is a biologic medication used to treat moderate-to-severe eczema, asthma, and allergic conditions, representing the type of specialty pharmaceutical commodity that DLA procures to support military healthcare systems and programs.
This delivery order exemplifies the operational execution of DLA's pharmaceutical supply chain through established prime vendor relationships. AmerisourceBergen, as a major pharmaceutical distributor, fulfills critical medical supply requirements across multiple therapeutic domains for military treatment facilities and veteran healthcare programs. The non-set-aside designation indicates this award was made through open competition on the underlying indefinite delivery vehicle, demonstrating the contractor's competitive capability to meet federal procurement standards for specialized pharmaceutical products at the point of delivery.
Quick answers
Who was awarded contract SPE2DR26FF111?
SPE2DR26FF111 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on February 3, 2026.
How much is contract SPE2DR26FF111 worth?
The government has obligated $16,628 on SPE2DR26FF111.
Is contract SPE2DR26FF111 an order under another contract?
Yes. SPE2DR26FF111 is a delivery order under SPE2DR25D1103, an indefinite delivery contract.
Was contract SPE2DR26FF111 competed?
The extent of competition for SPE2DR26FF111 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award